NLRP3 and neoplasm: In metastatic melanoma, tumor-associated NLRP3/IL-1β signaling induced expansion of MDSCs, leading to reduced NK and CD8+ T-cell activity concomitant with an increased presence of Treg cells in the primary tumors.